Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PQR309 + Eribulin in Advanced Breast Cancer
NCT02723877Phase 2Completed
- Sponsor
- PIQUR Therapeutics AG
- Start
- Mar 2016
- Primary completion
- Oct 2018
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of bimiralisib in breast cancer, sponsored by PIQUR Therapeutics AG. Started Mar 2016; status: completed.
02
Drugs
bimiralisib
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT02723877.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02723877.